SK282066B6 - Galenická forma derivátov 5-nitroimidazolu, farmaceutický prostriedok a použitie - Google Patents

Galenická forma derivátov 5-nitroimidazolu, farmaceutický prostriedok a použitie Download PDF

Info

Publication number
SK282066B6
SK282066B6 SK914-96A SK91496A SK282066B6 SK 282066 B6 SK282066 B6 SK 282066B6 SK 91496 A SK91496 A SK 91496A SK 282066 B6 SK282066 B6 SK 282066B6
Authority
SK
Slovakia
Prior art keywords
microgranules
galenic form
form according
gastroresistant
sustained release
Prior art date
Application number
SK914-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK91496A3 (en
Inventor
G�Rard Leduc
Patrice Debregeas
Original Assignee
Laboratoires Des Produits Ethiques Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Laboratoires Des Produits Ethiques Ethypharm filed Critical Laboratoires Des Produits Ethiques Ethypharm
Publication of SK91496A3 publication Critical patent/SK91496A3/sk
Publication of SK282066B6 publication Critical patent/SK282066B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK914-96A 1994-01-14 1995-01-12 Galenická forma derivátov 5-nitroimidazolu, farmaceutický prostriedok a použitie SK282066B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
PCT/FR1995/000039 WO1995019168A1 (fr) 1994-01-14 1995-01-12 Microgranules de derives de 5-nitro imidazole

Publications (2)

Publication Number Publication Date
SK91496A3 SK91496A3 (en) 1996-12-04
SK282066B6 true SK282066B6 (sk) 2001-10-08

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
SK914-96A SK282066B6 (sk) 1994-01-14 1995-01-12 Galenická forma derivátov 5-nitroimidazolu, farmaceutický prostriedok a použitie

Country Status (19)

Country Link
JP (1) JPH09507499A (es)
KR (1) KR100320140B1 (es)
CN (1) CN1088357C (es)
AT (1) ATE187068T1 (es)
AU (1) AU705570B2 (es)
BR (1) BR9506507A (es)
CZ (1) CZ286080B6 (es)
DE (1) DE69513632T2 (es)
DK (1) DK0739201T3 (es)
ES (1) ES2139883T3 (es)
MA (1) MA23429A1 (es)
MX (1) MX9602772A (es)
NZ (1) NZ279238A (es)
OA (1) OA10583A (es)
PL (1) PL178424B1 (es)
PT (1) PT739201E (es)
RU (1) RU2152212C1 (es)
SK (1) SK282066B6 (es)
UA (1) UA28031C2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
AU7909691A (en) * 1990-05-14 1991-12-10 Gary R. Jernberg Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
BR9506507A (pt) 1997-09-09
DE69513632D1 (de) 2000-01-05
PL315530A1 (en) 1996-11-12
AU705570B2 (en) 1999-05-27
MX9602772A (es) 1997-05-31
CZ286080B6 (cs) 2000-01-12
SK91496A3 (en) 1996-12-04
CN1088357C (zh) 2002-07-31
CN1138826A (zh) 1996-12-25
NZ279238A (en) 1998-03-25
AU1580395A (en) 1995-08-01
PL178424B1 (pl) 2000-04-28
UA28031C2 (uk) 2000-10-16
DK0739201T3 (da) 2000-05-01
MA23429A1 (fr) 1995-10-01
DE69513632T2 (de) 2000-04-06
ES2139883T3 (es) 2000-02-16
KR100320140B1 (ko) 2002-07-02
ATE187068T1 (de) 1999-12-15
JPH09507499A (ja) 1997-07-29
CZ205596A3 (en) 1996-10-16
OA10583A (en) 2002-07-10
RU2152212C1 (ru) 2000-07-10
PT739201E (pt) 2000-05-31

Similar Documents

Publication Publication Date Title
US5529790A (en) Delayed, sustained-release diltiazem pharmaceutical preparation
JP5366549B2 (ja) 即時放出特性及び／又は制御放出特性を有する薬学的剤形
US8968777B2 (en) Tranexamic acid formulations with reduced adverse effects
BRPI0608853B1 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
JPH04224517A (ja) 標的制御釈放薬剤
SK78694A3 (en) Solid medicamentous form with regulated release of drug and method of its preparing
JPH037238A (ja) 持続性製剤用薬物放出制御膜
NZ763555A (en) Delayed release deferiprone tablets and methods of using the same
AU2008365126A1 (en) Tamsulosin pellets for fixed dose combination
JP2004512298A (ja) 遅延及び持続放出製剤、及びそれを使用する方法
US5549911A (en) Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
EP1539113A2 (en) Modified release ketoprofen dosage form
SK282066B6 (sk) Galenická forma derivátov 5-nitroimidazolu, farmaceutický prostriedok a použitie
CA2038400A1 (en) Long acting granular pharmaceutical composition
EP0739201B1 (fr) Microgranules de derives de 5-nitro imidazole
JP2007516282A (ja) 放出制御医薬製剤
WO2023089553A1 (en) Controlled release formulations of flavoxate and process for preparation thereof
WO2013186191A1 (en) Formulations of metronidazole for the treatment of pouchitis
MX2008004282A (es) Formas de dosificacion farmaceuticas que tienen propiedades de liberacion inmediata y/o liberacion controlada